Filter
8703
Filtered Results: 8703
Text search:
key
diseases
Featured
Recommendations
767
New Publications
2284
Language
Document type
No document type
4714
Studies & Reports
1569
Guidelines
1055
Manuals
451
Strategic & Response Plan
350
Fact sheets
232
Training Material
140
Situation Updates
85
Resource Platforms
30
Infographics
28
Online Courses
28
Brochures
17
Dashboards/Maps
2
App
1
Videos
1
Countries / Regions
Global
388
India
349
Kenya
272
Sierra Leone
220
Ethiopia
200
Liberia
187
South Africa
184
Uganda
172
Nigeria
167
Western and Central Europe
159
Nepal
157
Malawi
136
Africa
131
Bangladesh
127
Rwanda
123
Latin America and the Carribbean
123
Myanmar / Burma
120
Zambia
118
Tanzania
114
Ghana
101
Syria
93
Congo, Democratic Republic of
86
Ukraine
81
Philippines
69
Namibia
68
Guinea
66
South–East Asia Region
66
South Sudan
65
Mozambique
63
Zimbabwe
60
Cambodia
56
Lesotho
54
West and Central Africa
54
Asia
54
Eastern Europe
52
East and Southern Africa
49
Haiti
47
Middle East and North Africa
47
Yemen
45
Senegal
44
Russia
43
Indonesia
36
Brazil
34
Botswana
33
Eastern Europe and Central Asia
33
Cameroon
30
Pakistan
30
Burkina Faso
29
Eswatini/ Swaziland
25
Afghanistan
23
Sudan
23
Venezuela
23
Somalia
22
Western Pacific Region
22
Germany
20
Thailand
20
Mali
19
Colombia
19
Benin
17
Madagascar
17
USA
15
Jordan
14
Central African Republic
14
Lebanon
13
Sri Lanka
13
Tajikistan
13
Vietnam
13
North America
13
Côte d’Ivoire / Ivory Coast
12
Laos
12
Georgia
12
Iraq
11
Peru
11
Moldova
11
China
10
Angola
10
North Macedonia
9
Chile
9
Albania
9
Niger
8
Chad
8
Papua New Guinea
8
Guinea-Bissau
7
Burundi
7
Palestine
7
Southern Africa
7
United Kingdom
7
Saudi Arabia
6
Turkey
6
Ecuador
6
Libya
6
Iran
6
Kyrgyzstan
6
Kazakhstan
6
Togo
5
Egypt
5
Gambia
5
Poland
5
Armenia
5
Timor Leste/ East Timor
5
Jamaica
5
Argentina
4
Hungary
4
Greece
4
Mexico
4
Paraguay
4
Romania
4
Turkmenistan
4
Tunisia
4
Malaysia
3
Serbia
3
El Salvador
3
Bolivia
3
Bhutan
3
Italy
3
Canada
3
Uzbekistan
3
Mauritius
3
Spain
3
Belarus
3
Morocco
2
Mauritania
2
Ireland
2
Vanuatu
2
Honduras
2
Fiji
2
North Korea
2
Djibouti
2
Mongolia
2
Qatar
2
Bulgaria
2
Slovakia
2
Gabon
2
Japan
2
Portugal
2
Israel
2
Bosnia and Herzegovina
2
Singapore
1
Dominican Republic
1
Croatia
1
Guatemala
1
Cape Verde
1
Other region
1
Solomon Islands
1
Congo-Brazzaville
1
Estonia
1
Lithuania
1
Denmark
1
Belgium
1
France
1
Maldives
1
South Korea
1
Algeria
1
Morocco
1
Barbados
1
Authors & Publishers
Publication Years
Category
Countries
3253
Clinical Guidelines
616
Public Health
540
Key Resources
409
Women & Child Health
384
Capacity Building
181
Pharmacy & Technologies
80
Annual Report MEDBOX
3
Toolboxes
COVID-19
923
HIV
715
Mental Health
566
TB
425
Planetary Health
355
Ebola
321
AMR
275
Rapid Response
273
Disability
239
Caregiver
232
NCDs
226
NTDs
216
Conflict
211
Global Health Education
154
Refugee
133
Natural Hazards
127
Pharmacy
123
Health Financing Toolbox
98
Cholera
73
Zika
65
Polio
50
Specific Hazards
43
Social Ethics
24
Typhoon
6
Health Financing
3
South Sudan
2
Background: A recent report by the Institute for Health Metrics and Evaluation (IHME) highlights that mental health receives little attention despite being a major cause of disease burden. This paper extends previous assessments of development assis...
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden of communicable and noncommunicable ... and rapid urbanization. There is also high income inequality among the population.
Training manual
Part 3: Use Safe Burial Practices
Important Guideline for Ebola prevention and control
It is designed for the following uses:
- for prevention through preparedness--to help African health facilities make advance preparations for responding with appropriate precautions when a VHF (including Ebola) case is suspected.
- for pl...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Supplement article
The Journal of Infectious Diseases® 2017;216(S7):S675–8
DOI: 10.1093/infdis/jix368
Finding the Missing Tuberculosis Patients • JID 2017:216 (Suppl 7) • S675
Downloaded from https://academic.oup.com/jid/article-abs...
Guidance Brief
Selected findings from ECDC and EMCDDA scientific guidance, 2018
second edition
Included more self-measured blood pressure (SMBP)-focused content with tools and resources.
Showcased more tools to find patients with potentially undiagnosed HTN.
Added new strategies that focus on chronic kidney disease testin...
The document provides the NICE Quality Standard for managing Type 2 diabetes in adults (QS209). It outlines evidence-based recommendations for preventing Type 2 diabetes, structured education, continuous glucose monitoring (CGM), medication such as SGLT2 inhibitors, and regular care processes to mon...
The document provides quality standards for managing Type 1 diabetes in adults, emphasizing areas like structured education, continuous glucose monitoring (CGM), cardiovascular risk management, and diabetic foot assessment. It aims to improve care processes, reduce complications, and enhance patient...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like ... occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
